Dan Stokely - Jun 25, 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role
CFO
Signature
/s/ Daniel Stokely
Stock symbol
AMPE
Transactions as of
Jun 25, 2021
Transactions value $
-$30,600
Form type
4
Date filed
6/29/2021, 11:22 AM
Previous filing
May 19, 2021
Next filing
Oct 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPE Common Stock Options Exercise $9.68K +22.5K +79.46% $0.43 50.8K Jun 25, 2021 Direct
transaction AMPE Common Stock Sale -$40.3K -22.5K -44.28% $1.79 28.3K Jun 25, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE 1. Stock Option (Right to Buy) Options Exercise $0 -22.5K -7.95% $0.00 261K Jun 25, 2021 Common Stock 22.5K $0.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.